Skip to search formSkip to main contentSkip to account menu

CS 834

Known as: CS-834 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Carbapenems

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
Synthesis of carbapenem CS-834
  • L. Jun
  • 2007
  • Corpus ID: 102137263
Objective:To synthesize carbapenem CS-834.Methods:Using monocyclic 1β- lactam as a starting agent,CS-834 was synthesized via… 
2005
2005
Synthesis of Enantiomerically Pure N-Substituted 4-Hydroxypyrrolidin-2-one Derivatives
Optically active 4-substituted pyrrolidin-2-one substructures can be found in various biologically active compounds such as CS… 
2003
2003
In situ observation of the four-step dehydration process of the 1 beta-methylcarbapenem antibiotic CS-834 crystal by X-rays.
The 1 beta-methylcarbapenem antibiotic CS-834 takes six crystalline forms depending on ambient conditions. The X-ray powder… 
2002
2002
Physicochemical analyses of phase transition and dehydration processes of a new oral 1beta-methylcarbapenem antibiotic agent, CS-834.
The characterizations of the anhydrate (A-form), monohydrate (B1-form), and dihydrate (B2-form) of CS-834 were investigated by… 
2001
2001
Crystal Structure of a 1β-Methylcarbapenem Antibiotic, Pivaloyloxymethyl (1R,5S,6S)-6-[(R)-1-hydroxyethyl]-1-methyl-2-[[(R)-5-oxopyrrolidin-3-yl]thio]-1-carbapen-2-em-3-carboxylate, CS-834 Dihydrate
its polymorphism and pseudopolymorphism, since the bioavailability of pharmacologically active compounds is frequently dependent… 
2000
2000
In vitro activity of R-95867, the active metabolite of a new oral carbapenem, CS-834, against anaerobic bacteria.
The in vitro activity of R-95867, the active metabolite of a new oral carbapenem, CS-834, was compared with those of DU-6859a… 
2000
2000
Impact of a new quinolone, DU-6859a, and two oral carbapenems, CS-834 and L-084, on the rat and mouse caecal microflora.
We determined the influence of a new quinolone, DU-6859a, and two oral carbapenems, CS-834 and L-084, on the rat and mouse caecal… 
1999
1999
CS-834 (Sankyo).
CS-834, a carbapenem antibiotic from Sankyo, is in phase II clinical trials for respiratory and urinary tract infections. It is… 
1999
1999
CS-834 (Sankyo).
  • M. L. van Ogtrop
  • IDrugs : the investigational drugs journal
  • 1999
  • Corpus ID: 39960244
CS-834, a carbapenem antibiotic from Sankyo, is in phase II clinical trials for respiratory and urinary tract infections. It is… 
1998
1998
Efficacy of CS-834 against Experimental Pneumonia Caused by Penicillin-Susceptible and -Resistant Streptococcus pneumoniae in Mice
ABSTRACT The efficacy of CS-834, a novel oral carbapenem, was assessed by using a murine model of pneumonia caused by penicillin… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)